Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Food for thought

Food for thought

posted on Mar 06, 2007 06:21AM

Did some digging on some numbers re: ARMHY, and found the following:

They're one of three companies that the Motley Fool (FWIW) touts as "cash kings," meaning their cash-flow-relative-to-sales is high, at least above 15%. According to one of their latest 6k filings, as of dec 31 '06, ARM had 128.8 pounds sterling in cash, which translates into roughly 247 million USD. they also have been buying back their stock regularly over the past year (remember, their shares trade in the US as American Depository Receipts, or ADRs. One ADR represents 3 ordinary shares.) To date they've ammassed about 47 million ordinary shares, or roughly 15.8 million ADRs (let's just call them "US" shares), in their treasury. They have approx. 446 million US shares out. So, with about 250 million in cash and about 120 million worth of shares in their treasury (at about $7.50 USD/US share), they've got about 400 million to play with, should the need arise.

Note also that ARM has been/seems to still be in a lawsuit with Nazomi over patents, this one in the Northern Distric of Calif. Initially, the court granted ARM's request for summary judgment, but Nazomi appealed, and the case was remanded back to the Northern District for further analysis. It went to a Markman hearing. ARM says it clearly won that. Nazomi is again appealing, and that, right now, is where it stands.

So, ARM is certainly willing, at least in the Nazomi case, to "go the distance" to the Markman, if need be. Though, again as a reminder, in a venue largely reputed as friendly to their side.

Interesting to note that, far as licensing goes, ARM didn't bring in a whole lot more revenue last year that PTSC did. I don't have the numbers, and I'm sure they beat us, but it doesn't look to have been by the sort of overwhelming number that you might expect from a global licensing giant.

I don't know where any of this points, and as many here say, to their credit, remember that nothing is certain as far as our pending court case is concerned. ARM could settle, ARM could fight, ARM could even win.

FWIW, I'm betting on Mr. Roger Cook and team, who look to me to know very much what they're doing.

JMHO.

Share
New Message
Please login to post a reply